Abstract
Chronic pain syndrome is one of the most common geriatric syndromes. Chronic pain negatively affects the mobility and autonomy of the older person, reducing the quality of life and longevity. An active screening for chronic pain in the geriatric population improves the geriatric status. Treatment strategies for chronic pain in older patients include non-pharmacological measures as well as drug administration. However, advanced age is associated with high comorbidity, polypharmacy, and in some cases does not allow the active use of systemic non-steroidal anti-inflammatory drugs (NSAIDs). In this connection, the use of parenteral symptomatic slow-acting drugs, the representative of which is chondroitin sulfate (CS), becomes an alternative. The efficacy and safety of CS has been proven by the mean of clinical studies meta-analysis data of osteoarthritis treatment effectiveness with parenteral chondroitin sulfate, including patients with back pain.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
